PGI25 - Long-term cost per sustained virologic response in patients with Genotype 1 Chronic Hepatitis C virus treated with Viekira Pak +/- Ribavirin and standard of care in the US
| Autor: | Virabhak, S., Johnson, S., Parise, H., Saab, S., Juday, T., Marx, S., Sanchez, Y., Wang, A. |
|---|---|
| Zdroj: | In Value in Health May 2015 18(3):A226-A226 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect